The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 308.00
Ask: 308.50
Change: 14.50 (4.97%)
Spread: 0.50 (0.162%)
Open: 298.00
High: 308.00
Low: 285.50
Prev. Close: 291.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adrian Whitfield to step down as CEO

1 Jul 2014 07:00

RNS Number : 9651K
Synthomer PLC
01 July 2014
 



July 1st 2014

Adrian Whitfield to step down as Group Chief Executive in June 2015

Synthomer plc ('Synthomer' or the 'Company') today announces that Adrian Whitfield, Group Chief Executive, will step down after eight years with the Company. To allow sufficient time for a replacement to be found and an orderly transition to take place, Adrian will remain as Group Chief Executive and on the Board until 30 June 2015.

 

The Board will conduct a comprehensive search for the Company's next Chief Executive and a further announcement will be made in due course.

Neil Johnson, Chairman, said: "Over the past 8 years, Adrian has overseen Synthomer's transformation from a small, diversified chemical business to a world leading producer of aqueous polymers. He led the highly successful acquisition of PolymerLatex in 2011 and during his tenure the Company's revenues have more than doubled to over £1 billion.

 

Today the business has a robust balance sheet, strong cashflow and excellent management team. On behalf of the board, I would like to thank Adrian for his hard work and commitment. We are sorry to see him go and wish him all the best for the future."

Adrian Whitfield said:

 

"The 8 years that I have spent with Synthomer have been among the most rewarding of my career. I am proud of the significant turnaround that has been achieved and our track record of strong growth. I have been fortunate to work with a fantastic team and Synthomer's dedicated employees around the world.

 

With the business on a solid platform supported by a clear strategy for future growth, now is the right time in my career to step down and allow someone else to take Synthomer forward. While I remain completely focused on the job until my successor is in place, my thanks go to the Board and everyone at Synthomer for supporting me in leading the Company through such a successful period of its development."

 

 

Enquiries:

 

Synthomer plc

Neil Johnson, Chairman

 

Adrian Whitfield, Group Chief ExecutiveDavid Blackwood, Chief Financial Officer

 

 

 

 

+44 (0) 20 3603 5220 (c/o Pendomer)

 

+44 (0) 1279 442791

Pendomer CommunicationsCharles Armitstead

 

+44 (0) 20 3603 5224

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEASKEDAPLEFF
Date   Source Headline
5th Aug 20217:01 amRNSBoard Update
5th Aug 20217:00 amRNSInterim Results
20th Jul 202112:05 pmRNSSynthomer plc receives Green Economy Mark
19th Jul 20217:00 amRNSTrading Update
14th Jul 202111:02 amRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSAppointment of Non-Executive Director
6th Jul 202112:37 pmRNSDirector/PDMR Shareholding
25th Jun 202110:01 amRNSFurther re Appointment of Group CEO
23rd Jun 20217:00 amRNSAppointment of Group Chief Executive Officer
18th May 20213:53 pmRNSDirector Declaration
12th May 20212:56 pmRNSDirector Declaration
6th May 20214:17 pmRNSDirector Declaration
6th May 20213:15 pmRNSDirector/PDMR Shareholding
29th Apr 20214:01 pmRNSResult of AGM
21st Apr 20217:00 amRNSQ1 Trading Update
31st Mar 20219:00 amRNSDirector/PDMR Shareholding
31st Mar 20219:00 amRNSDirector/PDMR Shareholding
30th Mar 202110:56 amRNSAnnual Financial Report
19th Mar 20212:38 pmRNSDirector/PDMR Shareholding
12th Mar 20213:17 pmRNSDirector/PDMR Shareholding
12th Mar 20213:16 pmRNSDirector/PDMR Shareholding
12th Mar 20213:14 pmRNSDirector/PDMR Shareholding
12th Mar 20213:14 pmRNSDirector/PDMR Shareholding
11th Mar 20219:43 amRNSHolding(s) in Company
4th Mar 202112:43 pmRNSPreliminary results – correction
4th Mar 20217:00 amRNSPreliminary Results year ended 31 December 2020
1st Mar 202112:58 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSStatement RE: Press Speculation
22nd Feb 20214:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
19th Feb 20213:38 pmRNSHolding(s) in Company
14th Jan 20217:00 amRNSPre-Close Trading Update and Board Update
12th Jan 20219:36 amRNSHolding(s) in Company
6th Jan 20219:10 amRNSDirector Declaration
4th Jan 202110:09 amRNSDirector Declaration
23rd Dec 20204:54 pmRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSAppointment of New Chair
18th Nov 20207:00 amRNSInvestor Seminar
17th Nov 20201:34 pmRNSDirector/PDMR Shareholding
16th Oct 202010:33 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSQ3 Trading Update
7th Oct 20209:20 amRNSHolding(s) in Company
4th Sep 20203:15 pmRNSDirector Declaration
6th Aug 20207:00 amRNSInterim Results for six months ended 30 June 2020
27th Jul 202010:00 amRNSPost Stabilisation Notice
16th Jul 20207:00 amRNSAppointment of Non-Executive Director
8th Jul 20204:16 pmRNSHolding(s) in Company
8th Jul 20204:14 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSSynthomer announces the pricing of senior notes
16th Jun 202011:54 amRNSPre Stabilisation Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.